期刊文献+

利奈唑胺治疗社区获得性耐甲氧西林金黄色葡萄球菌肺炎老年患者一例并文献复习 被引量:4

Clinical therapeutic effect of Linezolid for community acquired MRSA: 1 case report and review of the literatures
原文传递
导出
摘要 目的探讨利奈唑胺治疗老年社区获得性耐甲氧西林金黄色葡萄球菌(MRSA)肺炎的效果。方法采用回顾性调查方法,对1例应用利奈唑胺治疗社区获得性MRSA感染的老年肺炎患者的临床资料进行分析,记录其治疗前后的临床症状变化。结果对于MRSA感染的老年肺炎患者,使用利奈唑胺能够有效抑制病原菌,并且不良反应少,治疗效果明显。结论在治疗MRSA感染的社区获得性肺炎患者过程中,早期、正确使用抗生素能够提高患者治愈率。 Objective To investigate the clinic effect of Linezolid for community acquired methicillin resistant staphylococcus aureus (MRSA) pneumonia. Methods The clinic data of the patient were collected from the First Affiliated Hospital of Sun Yat-Sen University, in addition, the body temperature and white blood cell counts were obtained as the index of treatment. Results It was proved that Linezolid was effeetive in treating eommunit), acquired MRSA pneumonia and showed well tolerance with few adverse events. Conclusion Linezolid demonstrated good clinical and antibacterial activity but very few adverse reactions in elderly patients with community acquired MRSA pneumonia.
出处 《中国综合临床》 2011年第7期697-700,共4页 Clinical Medicine of China
基金 广东省科技计划项目
关键词 肺炎 社区获得性感染 利奈唑胺 金黄色葡萄球菌 Pneumonia Community acquired infection Linezolid Staphylococcus aureus
  • 相关文献

参考文献12

二级参考文献58

共引文献107

同被引文献31

  • 1甲氧西林耐药的金黄色葡萄球菌肺炎诊治与预防专家共识[J].中国医学前沿杂志(电子版),2013,5(1):45-50. 被引量:26
  • 2杜飞,马筱玲.儿童社区获得性耐甲氧西林金黄色葡萄球菌感染及防治[J].中国实用儿科杂志,2007,22(10):788-790. 被引量:6
  • 3Patterson CM, Loebinger MR. Community acquired pneumonia:assessment and treatment [ J]. Clin Med,2012,12(3) :283-286.
  • 4Torres A,Ramirez P,Montull B,et al. Biomarkers and community-acquired pneumonia : tailoring management with biological data[J]. Semin Respir Crit Care Med,2012,33(3) :266-271.
  • 5Albrich WC, Dusemund F, Riiegger K, et al. Enhancement ofCURB65 score with proadrenomedullin (CURB65-A) for outcomeprediction in lower respiratory tract infections : derivation of aclinical algorithm [J]. BMC Infect Dis,2011,11:112.
  • 6Espana PP,Capelastegui A,Bilbao A,et al. Utility of twobiomarkers for directing care among patients with non-severecommunity-acquired pneumonia [ J ]. Eur J Clin Microbiol InfectDis,2012,31( 12) :3397-3405.
  • 7Kriiger S, Frechen D. Another brick in the wall: adrenomedullinand prognosis in community-acquired pneumonia [ J]. Eur RespirJ,2012,39(5) :1060-1061.
  • 8Di Paola R, Talero E, Galuppo M, et al. Adrenomedullin ininflammatory process associated with experimental pulmonaryfibrosis [J]. Respir Res,2011,12:41.
  • 9Bello S, Lasierra AB, Minchol E. Prognostic power ofproadrenomedullin in community-acquired pneumonia isindependent of aetiology [J]. Eur Respir J, 2012 ,39 ( 5 ) : 1144-1155.
  • 10曹江红,李光辉.英国社区MRSA感染的诊断与处理指南[J].中国感染与化疗杂志,2008,8(6):476-478. 被引量:32

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部